Imunon regains Nasdaq minimum bid price compliance; delisting hearing pending on equity deficiency

Imunon, Inc.

Closing bid price above $1.00 for 10 consecutive days as of June 6, 2025, meeting bid price requirement.
Delisting determination received May 28 for bid price and equity rule violations; hearing requested May 29 stays suspension.
Warrant exercises on May 30 and June 2 provide $2.0M net proceeds, raising equity to $3.0M as of May 31.
Panel hearing will determine continued listing; company expects stock to remain listed until decision.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.